A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of VS 105

Summary

The purpose of the study is to evaluate the safety, tolerability, and PK following single and multiple ascending dose administration of VS-105 in healthy subjects and patients with chronic kidney disease stage 5D (CKD-5D) on hemodialysis.

Timeline

Start

2017-01-24

Primary completion

2018-03-31

Completion

2018-03-31

Drugs

Indications